National compliance to an evidence-based multidisciplinary guideline on XXXX .

@entity5 @entity3123 @entity1 @entity788
BACKGROUND: We evaluated national compliance to selected quality indicators from the Dutch multidisciplinary evidence-based guideline on @entity3123 and identified areas for improvement. METHODS: Compliance to 3 selected quality indicators from the guideline was evaluated before and after implementation of the guideline in 2011: 1) adjuvant chemotherapy after @entity5 resection for @entity3123 , 2) discussion of the @entity1 within a multidisciplinary team (MDT) meeting and 3) a maximum 3-week interval between final MDT meeting and start of treatment. RESULTS: In total 5086 @entity1 with @entity3123 were included. In 2010, 2522 @entity1 were included and in 2012, 2564 @entity1 . 1) Use of adjuvant chemotherapy following resection for @entity3123 increased significantly from 45% (120 out of 268) in 2010 to 54% (182 out of 336) in 2012 which was mainly caused by an increase in @entity1 aged <75 years. 2) In 2012, 64% (896 of 1396) of @entity1 suspected of a @entity3123 was discussed within a MDT meeting which was higher in @entity1 aged <75 years and @entity1 starting treatment with curative intent. 3) In 2012, the recommended 3 weeks between final MDT meeting and start of treatment was met in 39% (141 of 363) of @entity1 which was not influenced by @entity1 and @entity5 characteristics. CONCLUSION: Compliance to three selected quality indicators in @entity788 care was low in 2012. Areas for improvement were identified. Future compliance will be investigated through structured audit and feedback from the Dutch @entity788 Audit.
